| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/20/2013 | CN102978169A Methods of producing influenza vaccine compositions |
| 03/20/2013 | CN102978168A gM-negative EHV-mutants without heterologous elements |
| 03/20/2013 | CN102978167A Method for preparing nephropathogenic avian infectious bronchitis viruses and live vaccines by using cell lines |
| 03/20/2013 | CN102978166A Method for preparing newcastle disease viruses and vaccines by using serial passage cells, and products thereof |
| 03/20/2013 | CN102977195A Hiv疫苗 Hiv Vaccine |
| 03/20/2013 | CN102973931A Production process for improving titer of swine fever live vaccine product |
| 03/20/2013 | CN102443571B Chicken-origin H9N2 avian influenza virus strain and application thereof |
| 03/20/2013 | CN102399755B Pig pseudorabies virus natural low-virulent C strain and heatproof preservation method thereof |
| 03/20/2013 | CN102250917B Method for preparing IL28B and special recombinant bacterium |
| 03/20/2013 | CN102220287B Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof |
| 03/20/2013 | CN102206261B Plant fertility-related protein as well as encoding gene and application thereof |
| 03/20/2013 | CN102168073B Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production |
| 03/20/2013 | CN101977616B Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci |
| 03/20/2013 | CN101970644B Novel bacteriophage and antibacterial composition comprising the same |
| 03/20/2013 | CN101926992B Recombined attenuated live vaccine for preventing and treating I-type infection of herpes simplex virus and preparation method thereof |
| 03/20/2013 | CN101748101B Method for producing porcine reproductive and respiratory syndrome viruses |
| 03/19/2013 | US8399236 System comprising bacteriophages and particles that contain active substances |
| 03/19/2013 | US8398969 Compositions and methods for the treatment of viral hepatitis |
| 03/19/2013 | CA2656259C Process for producing poxviruses and poxvirus compositions |
| 03/19/2013 | CA2491907C Oncolytic virus replicating selectively in tumor cells |
| 03/19/2013 | CA2426172C Nucleic acid amplification controls |
| 03/19/2013 | CA2416203C Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 03/19/2013 | CA1341634C Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues acertains de ces virus et, le cas echeant, a la vaccination contre le sida |
| 03/14/2013 | WO2013036812A1 Functionalized carboxylic acids and alcohols by riverse fatty acid oxidation |
| 03/14/2013 | WO2013036118A1 Removal of contaminating viruses from aav preparations |
| 03/14/2013 | WO2013035906A1 Method for preventing and treating salmonella typhimurium infection |
| 03/14/2013 | WO2013034069A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof |
| 03/14/2013 | WO2013001285A3 Fmdv vp1 peptides |
| 03/14/2013 | US20130065296 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 03/14/2013 | US20130065275 Serum-free mammalian cell culture medium, and uses thereof |
| 03/14/2013 | US20130064879 Compositions and Methods for Inhibiting Viral Replication |
| 03/14/2013 | CA2848117A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof |
| 03/14/2013 | CA2847604A1 Removal of contaminating viruses from aav preparations |
| 03/14/2013 | CA2846870A1 A conditional replicating cytomegalovirus as a vaccine for cmv |
| 03/14/2013 | CA2846372A1 Oncolytic herpes simplex virus and therapeutic uses thereof |
| 03/13/2013 | EP2566958A1 Novel method |
| 03/13/2013 | EP2566957A2 Vaccine against beta-herpesvirus infection and use thereof |
| 03/13/2013 | EP2566956A1 Lentiviral vector based immunological compounds against malaria |
| 03/13/2013 | EP2566491A2 Modified rodent parvovirus capable of propagating and spreading through human gliomas |
| 03/13/2013 | CN102971425A Live attenuated chimeric porcine circovirus vaccine |
| 03/13/2013 | CN102971417A Isolation of a virus related to canine parvovirus-2 from a raccoon |
| 03/13/2013 | CN102971010A Recombinant CDV compositions and uses thereof |
| 03/13/2013 | CN102965348A Bovine viral diarrhea-mucosal virus with modified erns protein |
| 03/13/2013 | CN102965347A Preparation method of recombinant adeno-associated virus expressing hsa-miR-21<*> and application in treatment of hypertension |
| 03/13/2013 | CN102965346A Production technology of hyphantria cunea nuclear polyhedrosis virus |
| 03/13/2013 | CN102965345A Porcine parvovirus, vaccine composition and application thereof |
| 03/13/2013 | CN102965344A Production of infectious bronchitis virus and vaccine from cell line |
| 03/13/2013 | CN102965332A Swine testicular clone cell line and production method of classical swine fever live vaccine |
| 03/13/2013 | CN102964436A Plant salt-resistant disease-resistant related protein NtNHX1, and coding gene and application thereof |
| 03/13/2013 | CN102964434A Recombinant encephalitis B virus and application thereof |
| 03/13/2013 | CN102964432A Method for restraining phosphorylation of M1 protein of influenza virus A and applications of method |
| 03/13/2013 | CN102961757A Pseudovirus particle vaccine carrying double-stranded RNA target antigen and neutralizing antigen |
| 03/13/2013 | CN102352346B Novel-pathotype duck reovirus and attenuated vaccine thereof |
| 03/13/2013 | CN102329782B Avian flavivirus isolation strain and application thereof in preparation of vaccine |
| 03/13/2013 | CN102234634B High-transduction-efficiency hepatophilic cell hepatitis C virus pseudo-particle and envelope protein coded sequence thereof |
| 03/13/2013 | CN102076911B Composition and recording sheet with improved optical properties |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101058800B Animal protein free media for cultivation of cells |
| 03/12/2013 | US8394620 Two-component genome flavivirus and uses thereof |
| 03/12/2013 | CA2789539A1 Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
| 03/12/2013 | CA2354599C Binding molecules for human factor viii and factor viii-like proteins |
| 03/12/2013 | CA2295552C Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 03/07/2013 | WO2013032942A1 Influenza viruses with mutant pb2 gene segment as live attenuated vaccines |
| 03/07/2013 | WO2013031956A1 NUCLEIC ACID CONSTRUCT INCLUDING NUCLEIC ACID DERIVED FROM GENOTYPE 3a HCV GENOME |
| 03/07/2013 | WO2013030608A1 Nanoparticle-based veterinary vaccine |
| 03/07/2013 | WO2013030176A2 Live attenuated influenza virus |
| 03/07/2013 | WO2013004396A3 Adeno-parvovirus chimera with enhanced oncolytical potential |
| 03/07/2013 | US20130059732 Aav capsid proteins for nucleic acid transfer |
| 03/07/2013 | US20130059362 Biosensors comprising protein-binding domains and fluorescent proteins |
| 03/07/2013 | US20130059339 Apparatus and Methods for Cell Culture |
| 03/07/2013 | US20130058968 Piscine reovirus immunogenic compositions |
| 03/07/2013 | US20130058897 Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same |
| 03/07/2013 | CA2847173A1 Viral clearance methods |
| 03/07/2013 | CA2847115A1 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 3a |
| 03/06/2013 | EP2563909A1 Improved production of virus replicon particles in packaging cells |
| 03/06/2013 | EP2563387A1 Adenovirus vaccine vectors |
| 03/06/2013 | CN102952785A Porcine pseudorabies virus, and vaccine composition and applications thereof |
| 03/06/2013 | CN102952784A Method for producing RHD (rabbit haemorrhagic disease) vaccine by use of cell line and product thereof |
| 03/06/2013 | CN102952783A Newcastle disease virus NDV PY strain and application thereof |
| 03/06/2013 | CN102949716A Method for preparing inactivated rabies vaccine for animal by bioreactor |
| 03/06/2013 | CN102949715A Method for preparing inactivated Japanese encephalitis vaccine by bioreactor |
| 03/06/2013 | CN102399754B H9N2 avian influenza virus vaccine strain and application of H9N2 avian influenza virus vaccine strain in immune protection |
| 03/06/2013 | CN102071218B Peste des petits ruminants virus (PPRV) reverse genetic operating system and application thereof |
| 03/06/2013 | CN101934074B Porcine circovirus II vaccine and production method thereof |
| 03/05/2013 | US8389706 Vaccines for human papilloma virus and methods for using the same |
| 03/05/2013 | US8389261 Method of isolation and purification of trypsin from pronase protease and use thereof |
| 03/05/2013 | US8388944 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 03/05/2013 | US8388847 Methods of concentrating shear-sensitive biopolymers |
| 03/05/2013 | CA2570050C Heart and skeletal muscle inflammation (hsmi) virus |
| 02/28/2013 | WO2013029030A1 New aav capsid proteins for nucleic acid transfer |
| 02/28/2013 | WO2013027988A2 Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof |
| 02/28/2013 | WO2013027427A1 Conditionally replication-competent adenovirus |
| 02/28/2013 | WO2013027146A1 The method of obtaining a strain of bacteriofage, specific strains of bacteriophage and use thereof |
| 02/28/2013 | US20130052718 Attenuated human parainfluenza virus, methods and uses thereof |
| 02/28/2013 | US20130052717 Mdck cell lines supporting viral growth to high titers and bioreactor process using the same |
| 02/28/2013 | US20130052716 Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7 |
| 02/28/2013 | US20130052225 Infectious dna vaccines against chikungunya virus |
| 02/28/2013 | US20130052224 Production of poliovirus at high titers for vaccine production |
| 02/28/2013 | US20130052219 Preparation method of virus expressing alpha-galactose epitope and vaccine |
| 02/28/2013 | US20130052218 Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions |